Core One Labs’ Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases – Yahoo Finance

Related Articles:

• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• Silo Pharma Plans Phase 2B Trial Testing Low-dose Psychedelics in Parkinson’s December 4, 2020 Silo Pharma is collaborating with Maastricht University on a Phase 2b clinical trial to investigate the effects of low-dose psychedelics on cognitive and emotional dysfunction in patients with Parkinson’s disease. “The signing of this clinical study agreement represents a significant milestone for the Company as we continue our work to bring novel therapeutics to patients in need,” Eric Weisblum, chairman…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Coming Soon…the Rune Labs’ Patient Advisory Board February 10, 2022 Back in the good ol’ pre-covid days of 2018, I went to my neurologist, Dr. Alfonso Fasano, with an idea about speaking to the doctors at my clinic about the journey I’d been on as a patient advocate. He loved it and arranged a talk at the Toronto Western Hospital (TWH) for the entire Movement Disorder Clinic (MDC). Among those…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences - Yahoo Finance January 26, 2022 Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences  Yahoo Finance
• ASAP 2021 funding November 8, 2021   # # # # Aligning Science Across Parkinson’s represents a major new funder for Parkinson’s research. They are focused on basic biology research and require their grant holders to take a very collaborative, interdisciplinary, “open science” approach. In their first 2 years of funding, the organisation has awarded almost US$300 million in grants. That is kind of… how should…
• Core One Labs' Akome Move Psychedelic Drug Formulations to Next Stage of Development: Initiating Phase 2 Analysis of Therapeutic Potential - Yahoo Finance September 16, 2022 Core One Labs' Akome Move Psychedelic Drug Formulations to Next Stage of Development: Initiating Phase 2 Analysis of Therapeutic Potential  Yahoo Finance
• The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry - Cureus September 14, 2022 The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry  Cureus
• Core One Labs’ Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations - Yahoo Finance March 4, 2022 Core One Labs’ Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations  Yahoo Finance
• Core One Labs’ Akome Receives Positive Results from Bioassay Studies - Yahoo Finance April 2, 2022 Core One Labs’ Akome Receives Positive Results from Bioassay Studies  Yahoo Finance
• Core One Labs’ Akome Seeks to Revolutionize Treatment of Parkinson’s Disease and Submits Application to Protect IP - Yahoo Finance July 26, 2021 Core One Labs’ Akome Seeks to Revolutionize Treatment of Parkinson’s Disease and Submits Application to Protect IP  Yahoo Finance
• Core One Labs' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies - GlobeNewswire March 4, 2022 Core One Labs' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies  GlobeNewswire
• Core One Labs' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations - BioSpace March 4, 2022 Core One Labs' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations  BioSpace
• Core One Labs' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations - StreetInsider.com March 4, 2022 Core One Labs' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies: Advancing its Proprietary Psychedelic-based Pharmaceutical Formulations  StreetInsider.com
• Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech - GlobeNewswire April 29, 2021 Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech  GlobeNewswire
• Core One Labs' Akome Seeks to Revolutionize Treatment of Parkinson's Disease and Submits Application to Protect IP - Financial Post July 26, 2021 Core One Labs' Akome Seeks to Revolutionize Treatment of Parkinson's Disease and Submits Application to Protect IP  Financial Post
• Monthly Research Review – June 2022 June 30, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during June 2022. The post is divided into 10 parts based on the type of research: Top 7 pieces of Parkinson’s news Articles of general interest Basic biology…
• Parkinson's Disease News - Editor's Picks (Archive 2016.09) October 15, 2016 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed ‘The Terrorist Inside My Husband’s Brain’: Robin Williams’ Widow Details His Disease – Live ScienceLive Science'The Terrorist Inside My Husband's Brain': Robin Williams' Widow Details His DiseaseLive ScienceBut Robin Williams was not diagnosed with Lewy body disease…
• What’s In Your Network? November 10, 2022 ¿Qué hay en tu red? I am a translator, and at work, I often have the chance to interact with colleagues who are in training. Whenever I can, I strongly encourage them to participate in associations and, if possible, to attend in-person events. Why? Because having a network of contacts is essential when you are a translator: you never know…
• Animals in Parkinson's research October 22, 2022 Saturday 22 October 2022  Continuing with the theme of animal models, here is an essay I wrote as part of my MSc neuroscience about the use of animals in Parkinson’s research. Many people, myself included, feel uncomfortable about the use of animals in brain research, an issue for which there are no easy answers. There is quite a bit of…
• Monthly Research Review – October 2021 October 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…